Načítá se...
Systemic therapy for patients with advanced, unresectable ormetastatic renal cell carcinoma: moving to guidelines
Until recently, patients with advanced, unresectable or metastatic renal cell cancer (RCC) had very few therapeutic options. Cytokine therapy, consisting mainly of interferon-α and interleukin-2, was considered the mainstay of therapy. A better understanding of the biology of RCC has led to the deve...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Canadian Medical Association
2007
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2422947/ https://ncbi.nlm.nih.gov/pubmed/18542783 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|